Compare ATAT & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATAT | MMS |
|---|---|---|
| Founded | 2013 | 1975 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Business Services |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 4.7B |
| IPO Year | 2022 | 1997 |
| Metric | ATAT | MMS |
|---|---|---|
| Price | $42.95 | $84.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $46.16 | ★ $90.00 |
| AVG Volume (30 Days) | ★ 1.5M | 743.0K |
| Earning Date | 11-25-2025 | 11-20-2025 |
| Dividend Yield | 1.05% | ★ 1.42% |
| EPS Growth | ★ 25.36 | 10.42 |
| EPS | 1.48 | ★ 5.51 |
| Revenue | $1,276,315,178.00 | ★ $5,431,276,000.00 |
| Revenue This Year | $37.61 | $1.71 |
| Revenue Next Year | $23.33 | $4.98 |
| P/E Ratio | $28.91 | ★ $15.32 |
| Revenue Growth | ★ 36.24 | 2.36 |
| 52 Week Low | $21.50 | $63.77 |
| 52 Week High | $43.17 | $92.50 |
| Indicator | ATAT | MMS |
|---|---|---|
| Relative Strength Index (RSI) | 62.01 | 50.02 |
| Support Level | $40.80 | $81.65 |
| Resistance Level | $43.17 | $85.40 |
| Average True Range (ATR) | 1.43 | 2.01 |
| MACD | 0.20 | 0.00 |
| Stochastic Oscillator | 92.12 | 35.63 |
Atour Lifestyle Holdings Ltd is an upper-midscale hotel chain in China. The company derives revenues from franchise and management fees from its manachised hotels and sales of hotel supplies to manachised hotels, Operations of leased hotels, and sales of retail products. The company has one operating segment, which is the Atour Group.
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.